Spots Global Cancer Trial Database for endometrial clear cell adenocarcinoma

Every month we try and update this database with for endometrial clear cell adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer	NCT03836157	Endometrial Can... Endometrial Ade... Endometrial Ser... Endometrial Cle...	Mirvetuximab So... Bevacizumab	18 Years -	University of Oklahoma
Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00820898	Endometrial Ade... Endometrial Ade... Endometrial Cle... Recurrent Uteri...	Gemcitabine Hyd...	18 Years -	GOG Foundation
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00005840	Endometrial Cle... Endometrial Ser... Stage III Uteri... Stage IV Uterin...	Paclitaxel Cisplatin Radiation Thera...	18 Years -	GOG Foundation
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00005830	Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage III Uteri... Stage IV Uterin...	Doxorubicin Hyd... Cisplatin Radiation Thera...	18 Years -	GOG Foundation
AMT-151 in Patients With Selected Advanced Solid Tumours	NCT05498597	Advanced Solid ... Advanced Cancer Advanced Carcin... Ovarian Cancer Ovarian Carcino... Ovarian Epithel... Ovarian Endomet... Endometrial Can... Endometrial Ade... Endometrial Ser... Endometrial End... Endometrial Cle... Lung Adenocarci... Triple Negative... Pancreatic Duct... Malignant Pleur... Ovarian Clear C... Ovarian Clear C... Ovarian Mucinou...	AMT-151	18 Years -	Multitude Therapeutics Inc.
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma	NCT05112601	Endometrial Ade... Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Und... Endometrioid Ad... Recurrent Endom...	Biospecimen Col... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer	NCT05950464	Endometrial Car... Endometrial Cle... Endometrial End... Endometrial Low... Ovarian Clear C... Ovarian Endomet... Ovarian High Gr... Ovarian Low Gra... Platinum-Resist...	BET Bromodomain... Biopsy Biospecimen Col... Computed Tomogr... Electrocardiogr... Magnetic Resona... Tuvusertib X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT01935934	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Metastatic Endo... Recurrent Uteri... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri... Uterine Corpus ...	Cabozantinib S-... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00005840	Endometrial Cle... Endometrial Ser... Stage III Uteri... Stage IV Uterin...	Paclitaxel Cisplatin Radiation Thera...	18 Years -	GOG Foundation
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer	NCT03422198	Endometrial Cle... Endometrial End... Endometrial Ser... Stage I Uterine... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Uterine Corpus ... Uterine Corpus ...	Vaginal Cuff Br... Short course va...	-	University of Utah
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	NCT01005329	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Cisplatin Intensity-Modul... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer	NCT01440998	Endometrial Ade... Endometrial Cle... Endometrial Muc... Endometrial Ser... Endometrial Squ... Endometrial Tra... Endometrial Und... Endometrioid Ad... Recurrent Uteri... Stage III Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri...	Carboplatin Dasatinib Laboratory Biom... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT01225887	Endometrial Ade... Endometrial Cle... Endometrial Muc... Endometrial Ser... Endometrial Squ... Endometrial Tra... Endometrial Und... Malignant Uteri... Recurrent Uteri...	Nintedanib	18 Years -	GOG Foundation
Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT01642082	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Muc... Endometrial Ser... Endometrial Squ... Endometrial Tra... Endometrial Und... Recurrent Uteri...	Dalantercept Laboratory Biom...	18 Years -	GOG Foundation
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer	NCT02874430	Breast Carcinom... Endometrial Cle... Endometrial Ser... Uterine Corpus ... Uterine Corpus ...	Metformin Hydro... Doxycycline	18 Years -	Thomas Jefferson University
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors	NCT02142803	Adult Glioblast... Endometrial Cle... Endometrial Ser... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Solid Neoplasm Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar...	Bevacizumab Laboratory Biom... Pharmacological... Sapanisertib	18 Years -	National Cancer Institute (NCI)
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma	NCT05112601	Endometrial Ade... Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Und... Endometrioid Ad... Recurrent Endom...	Biospecimen Col... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in High-Risk Endometrial Cancers	NCT05049538	Endometrial Cle... Endometrial Ded... Endometrial Muc... Endometrial Ser... Malignant Uteri... Uterine Corpus ...	Biospecimen Col... Liquid Biopsy Pap Smear	18 Years -	M.D. Anderson Cancer Center
Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00820898	Endometrial Ade... Endometrial Ade... Endometrial Cle... Recurrent Uteri...	Gemcitabine Hyd...	18 Years -	GOG Foundation
Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00888173	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Muc... Endometrial Ser... Endometrial Squ... Endometrial Tra... Endometrial Und... Recurrent Uteri...	Brivanib Alanin... Laboratory Biom...	18 Years -	GOG Foundation
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer	NCT03914612	Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Ser... Endometrial Und... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Stage III Uteri... Stage IV Uterin...	Carboplatin Computed Tomogr... Paclitaxel Pembrolizumab Placebo Adminis... Quality-of-Life... Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer	NCT02059265	Endometrial Cle... Ovarian Clear C... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Uteri...	Dasatinib Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in High-Risk Endometrial Cancers	NCT05049538	Endometrial Cle... Endometrial Ded... Endometrial Muc... Endometrial Ser... Malignant Uteri... Uterine Corpus ...	Biospecimen Col... Liquid Biopsy Pap Smear	18 Years -	M.D. Anderson Cancer Center
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors	NCT02142803	Adult Glioblast... Endometrial Cle... Endometrial Ser... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Solid Neoplasm Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar...	Bevacizumab Laboratory Biom... Pharmacological... Sapanisertib	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00005830	Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage III Uteri... Stage IV Uterin...	Doxorubicin Hyd... Cisplatin Radiation Thera...	18 Years -	GOG Foundation
Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT01935973	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Endometrial Und... Recurrent Uteri...	Laboratory Biom... Trametinib Uprosertib	18 Years -	National Cancer Institute (NCI)
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer	NCT02059265	Endometrial Cle... Ovarian Clear C... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Uteri...	Dasatinib Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT01935934	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Metastatic Endo... Recurrent Uteri... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri... Uterine Corpus ...	Cabozantinib S-... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	NCT01005329	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Cisplatin Intensity-Modul... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00006011	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Ser... Stage III Uteri...	Doxorubicin Hyd... Cisplatin Filgrastim Pegfilgrastim Paclitaxel	-	GOG Foundation
Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol	NCT02501954	Endometrial Cle... Endometrial Ser... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri...	Cisplatin Carboplatin Paclitaxel Radiation Thera...	18 Years -	Women's Cancer Care Associates, LLC
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)	NCT05001282	Ovarian Cancer Ovarian Neoplas... Ovarian Carcino... Endometrial Can... Ovary Cancer Ovary Neoplasm Ovary Disease Ovary Metastasi... Ovarian Disease... Ovarian Cancer ... Ovarian Epithel... Ovarian Adenoca... Ovarian Serous ... Ovarian Neoplas... Ovarian Cancer ... Endometrial Dis... Endometrial Ade... Endometrial Car... Endometrial Cle... Endometrioid Ad... Endometrial Neo... Endometrial Can... Endometrioid Tu... Fallopian Tube ... Peritoneal Canc...	ELU001	18 Years -	Elucida Oncology
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer	NCT00575952	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Endometrial Squ... Endometrial Und... Recurrent Uteri... Stage IIIA Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Cisplatin Doxorubicin Hyd... Filgrastim Paclitaxel Pegfilgrastim	-	GOG Foundation
Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT01132820	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Recurrent Uteri...	Cediranib Malea... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer	NCT03836157	Endometrial Can... Endometrial Ade... Endometrial Ser... Endometrial Cle...	Mirvetuximab So... Bevacizumab	18 Years -	University of Oklahoma
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma	NCT05112601	Endometrial Ade... Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Und... Endometrioid Ad... Recurrent Endom...	Biospecimen Col... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	NCT00807768	Endometrial Cle... Endometrial Ser... Fatigue Neurotoxicity S... Obesity Stage I Uterine... Stage II Uterin...	3-Dimensional C... Carboplatin Intensity-Modul... Internal Radiat... Laboratory Biom... Paclitaxel Quality-of-Life... Questionnaire A...	18 Years -	GOG Foundation
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	NCT01005329	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Cisplatin Intensity-Modul... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer	NCT01307631	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Recurrent Uteri...	Akt Inhibitor M... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer	NCT00942357	Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri...	Carboplatin Cisplatin Internal Radiat... Paclitaxel Quality-of-Life... Radiation Thera...	18 Years -	GOG Foundation
Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT01210222	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Ser... Endometrioid St... Recurrent Uteri...	Trebananib	18 Years -	GOG Foundation
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	NCT00977574	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Recurrent Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Ixabepilone Laboratory Biom... Paclitaxel Temsirolimus	18 Years -	National Cancer Institute (NCI)
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00006011	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Ser... Stage III Uteri...	Doxorubicin Hyd... Cisplatin Filgrastim Pegfilgrastim Paclitaxel	-	GOG Foundation
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers	NCT02020707	Cervical Adenoc... Cervical Adenos... Cervical Adenos... Cervical Carcin... Cervical Squamo... Clinical Stage ... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Ser... Endometrial Und... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Malignant Femal... Malignant Ovari... Malignant Ovari... Malignant Ovari... Malignant Ovari... Malignant Perit... Malignant Solid... Ovarian Carcino... Ovarian Clear C... Ovarian Endomet... Ovarian High Gr... Ovarian Mucinou... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Platinum-Resist... Platinum-Resist... Platinum-Resist... Platinum-Sensit... Primary Periton... Primary Periton... Primary Periton... Primary Periton... Primary Periton... Unresectable Me... Uterine Corpus ...	Bevacizumab Laboratory Biom... Nab-paclitaxel Pharmacological...	18 Years -	Mayo Clinic
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer	NCT05950464	Endometrial Car... Endometrial Cle... Endometrial End... Endometrial Low... Ovarian Clear C... Ovarian Endomet... Ovarian High Gr... Ovarian Low Gra... Platinum-Resist...	BET Bromodomain... Biopsy Biospecimen Col... Computed Tomogr... Electrocardiogr... Magnetic Resona... Tuvusertib X-Ray Imaging	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: